National Bank analyst Giuliano Thornhill raised the firm’s price target on Extendicare (EXETF) to C$24.50 from C$21.50 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXETF:
- Extendicare upgraded to Outperform from Sector Perform at RBC Capital
- Extendicare resumed with Outperform from Market Perform at BMO Capital
- Extendicare’s Strategic Acquisition of CBI Home Health: A Catalyst for Growth and Investment Opportunity
- Extendicare Completes $200 Million Private Placement to Fund Strategic Acquisition